InspireMD announced today that Craig Shore, the company’s CFO, decided to retire after the company identifies and appoints a successor. Shore intends to remain as CFO until the stroke prevention company names his replacement to assist in a smooth and orderly transition. He spent 15 years at InspireMD, helping to build the business into “a […]
InspireMD
InspireMD begins pivotal study of CGuard Prime in TCAR procedures
InspireMD today announced it enrolled the first patient in its CGUARDIANS II pivotal study, which will evaluate the CGuard Prime Carotid Stent System in trans carotid artery revascularization (TCAR) procedures. The first patient was enrolled at Good Samaritan Hospital in Cincinnati, Ohio, by Dr. Patrick Muck, who is the co-lead investigator for the study. CGUARDIANS […]
InspireMD wins FDA IDE for carotid stent study
InspireMD (Nasdaq:NSPR) announced today that the FDA granted investigational device exemption (IDE) for its CGuard Prime 80cm carotid stent system. The FDA says the company can begin the CGUARDIANS II pivotal study of the system used during transcarotid revascularization (TCAR) procedures. InspireMD picked Dr. Patrick Geraghty and Dr. Patrick Muck to serve as lead investigators […]
InspireMD submits carotid stent for FDA premarket approval
InspireMD (Nasdaq:NSPR) announced today that it submitted a premarket approval (PMA) application to the FDA for its CGuard system. The company designed the CGuard Prime carotid stent system for the treatment of carotid artery stenosis. It based its PMA application on positive one-year data from the company’s C-GUARDIANS pivotal clinical trial. The trial evaluated the […]
InspireMD brings in $17.9M to support stent trial
InspireMD (Nasdaq:NSPR) announced today that it completed a full exercise of Series H warrants for proceeds of about $17.9 million. Tel Aviv, Israel-based InspireMD exercised 12.9 million warrants, converting primarily into pre-funded warrants. The gross proceeds for the company, which has a U.S. base in Westin, Florida, total $16.9 million after fees. InspireMD’s warrants came […]
InspireMD wins CE mark for carotid stent system
InspireMD (Nasdaq:NSPR) announced today that it received CE mark approval for its CGuard embolic prevention carotid stent system (EPS). The Tel Aviv, Israel-based company designed CGuard for the prevention of stroke. It utilizes the company’s MicroNet technology for strong acute results and durable, stroke-free, long-term outcomes. InspireMD highlighted the importance of the transition to the […]
InspireMD names Andrea Tommasoli as chief operating officer
InspireMD (NYSE:NSPR) this week announced it appointed Andrea Tommasoli as chief operating officer. Tommasoli was previously the company’s senior VP of global sales and marketing since November 2020. Prior to joining InspireMD, Tommasoli was most recently the senior sales director of indirect markets at Integra Lifesciences. “Andrea has been instrumental in expanding the footprint of CGuard […]
InspireMD grows sales 33% in Q3
InspireMD (NYSE:NSPR) this week posted third-quarter results that beat the overall consensus on Wall Street. The Tel Aviv, Israel-based company reported net losses of $4.5 million, or -58¢ per share, on sales of $1.43 million for the three months ended Sept. 30, for a sales growth of 33.61% compared with Q3 2021. Earnings per share […]
InspireMD sales up 231% in mixed-bag Q2 results
InspireMD (NYSE:NSPR) posted second-quarter results this week that beat the earnings consensus on Wall Street but missed revenue estimates. The Tel Aviv, Israel-based carotid stenting company reported losses of $3.5 million, or -46¢ per share, on sales of $1.03 million for the three months ended June 30, for a sales growth of 231.63% compared with Q2 […]
InspireMD dips despite Street-beating Q1
InspireMD (NYSE:NSPR) shares slid today despite first-quarter results that topped the consensus forecast. The Tel Aviv, Israel-based company posted losses of -$3.2 million, or -53¢ per share, on sales of $1 million for the three months ended March 31, 2021, for a -64% bottom-line slide on a sales decline of -2.7%. InspireMD’s EPS of -53¢ […]
InspireMD wins FDA approval for carotid stent system study
InspireMD today said it received FDA approval to proceed with a pivotal study of its CGuard Carotid Stent System. The investigational device exemption from the FDA will allow the company to study the device for the prevention of stroke in patients in the U.S. Get the full story on our sister site, Medical Tubing + […]
